Best or Worst IdeaDay 4: The Pivot
February 4, 2026 · Day 4 of 90
Time to Get Aggressive
Four days in. We're down 4% on VNDA. The FDA catalyst is still 17 days away.
That's too long.
The goal of this experiment isn't to beat the S&P by a few percent. It's to generate maximum gains in 90 days. We can't afford to sit on dead money waiting for a binary event that may or may not go our way.
Today, we pivoted.
🔄 The New Strategy
No more waiting weeks for catalysts. We're shifting to aggressive momentum trading:
- Chase unusual options activity — follow the big money
- Track congressional trades — politicians with "perfect timing"
- Monitor insider buying — executives loading up on their own stock
- Hunt imminent catalysts — earnings this week, not FDA dates next month
In and out in days, not weeks. Use every legal information edge available.
The Exit: VNDA
This morning I sold 127 of my 129 VNDA shares at $7.60.
I kept 2 shares (~$15) as a lottery ticket for the Feb 21 FDA decision. If Bysanti gets approved and the stock doubles, great — free upside. If not, I'm out $15.
| Action | Ticker | Shares | Price | Total |
|---|---|---|---|---|
| SELL | VNDA | 127 | $7.60 | $965.20 |
Result: We lost $43 on VNDA (-4.3% from our $7.82 entry). Not ideal, but waiting another 16 days for an uncertain catalyst isn't the play when we're hunting for 2x, 5x, 10x returns.
The Research: Finding Fast Money
With $965 in cash, I asked Claude to scan for the highest-conviction short-term plays. Not safe bets — fast money.
Claude dug into:
- Unusual options activity (Schwab, Barchart, InsiderFinance)
- Congressional stock trades (Capitol Trades, Quiver Quantitative)
- SEC Form 4 insider filings
- This week's FDA PDUFA calendar
- Earnings reports with recent big beats
One name kept coming up.
The Entry: IREN
Claude's Thesis: Why IREN?
IREN Limited (NASDAQ: IREN) — formerly Iris Energy — is an AI data center and Bitcoin mining company that just crashed 30% from its highs.
- Congressional Edge: Rep. Cleo Fields (D-LA) bought $50K-$100K of IREN on January 20. His track record? 73.90% returns over 12 months — crushing the market. He sits on the House Financial Services Committee with oversight of fintech and AI regulation.
- The Timing: Fields also loaded up on GOOGL, META, NFLX, and TSM in January. His previous "well-timed" trades include Oracle before a TikTok announcement.
- Immediate Catalyst: IREN reports earnings tomorrow (Feb 5). Last quarter they beat estimates by 614% ($1.07 EPS vs $0.15 expected).
- Microsoft Contract: $9.7B five-year deal for AI cloud services — real revenue, not speculation.
- Oversold: Down 30% in days on AI sector rotation. Analyst consensus target: $72.18 (43% upside from ~$50).
A congressman with a 73% hit rate just loaded up. Earnings tomorrow. Oversold technicals. This is the setup we're looking for.
The Trade
At market open tomorrow, I'm buying IREN with the full $965.
At ~$50/share, that's roughly 19 shares.
| Action | Ticker | Shares | Target Price | Total |
|---|---|---|---|---|
| BUY (pending) | IREN | ~19 | ~$50 | ~$965 |
The Game Plan
- Earnings pop (+10-20%): Sell into the morning rally, rotate to next play
- Earnings miss or flat: Reassess — might hold for technical bounce given oversold conditions
- Continued selloff: Cut losses quickly, find the next momentum trade
This isn't buy-and-hold. We're riding the congressman's coattails into an earnings catalyst.
Why This Matters
Congressional trades are public record. Politicians consistently outperform the market with suspicious timing. Whether it's legal information advantage or something else, the data is there.
We're not doing anything illegal — we're just paying attention to what the people with the best "timing" are buying.
Cleo Fields is up 243% on his IREN position since his initial buys. He bought more in January. Now earnings are tomorrow.
Sometimes the edge is just following the money.
Current Position
| Ticker | Shares | Status | Value |
|---|---|---|---|
| VNDA | 2 | Lottery ticket (Feb 21 FDA) | ~$15 |
| Cash | — | Ready for IREN buy | $965.20 |
Scoreboard
| Starting Capital | $1,000.00 |
|---|---|
| Current Value | $980.38 |
| VNDA P&L (closed) | -$43.58 (-4.3%) |
| Total Return | -1.96% |
| Day | 4 of 90 |
What's Next
Tomorrow morning: execute the IREN buy at market open.
Then we watch earnings. If Fields and the smart money are right, we catch a bounce. If not, we cut and move on.
86 days to go. Time to make them count.
Disclaimer: This is a personal experiment for entertainment and educational purposes, not financial advice. Trading stocks and options involves significant risk — you can lose some or all of your money. I am not a licensed financial advisor. Congressional trading data is publicly available but should not be construed as a recommendation. Do your own research before making any investment decisions. Past performance does not guarantee future results. If you sign up for Robinhood using my link, I may receive a referral bonus at no cost to you.